Showing results (1811-1820 of 7,773) with videos related to

Sort By:
Pageof 778
Pharmacological Research|May 15, 2026
NAT10-dependent ac4C mRNA modification programs fibroblast pathogenicity in systemic sclerosisWeibo Tang, Ye Xu, Wenya Liu, et al.
Pharmacological Research|May 17, 2026
Neocryptomerin targets NAE1 to induce DNA re-replication and DNA damage by inhibiting neddylation-mediated CDT1 degradation in gastric cancerPeng Tan, Dongjun Fu, Fei Wang, et al.
Pharmacological Research|May 10, 2026
Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glueAlfred Schinkel, Davinia Arguedas, Viët Bui, et al.
Pharmacological Research|May 19, 2026
Review article: Improving Mitochondrial Function: Current Therapeutic Perspectives in Neurodegenerative DiseasesJulia Brechtel, Christine Lietz, Selin Akpinar Adscheid, et al.
Pharmacological Research|May 12, 2026
Effect of intraoperative esketamine on moderate-to-severe depressive symptoms in major surgery patients: a randomized clinical trialYang Zhou, Wanchen Sun, Yuxuan Fu, et al.
Pharmacological Research|May 12, 2026
Mitochondria and Qi: Merging Eastern and Western MedicineWanqing Xie, Deborah G Murdock, Douglas C Wallace
Pharmacological Research|May 11, 2026
IUPHAR REVIEW: The Neurobiological Outcomes of Prenatal Opioid Exposure: Evidence from Preclinical ModelsDavian West, Brady K Atwood
Pharmacological Research|January 15, 2019
The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acidsR J F Felizardo, I K M Watanabe, Patrizia Dardi, et al.
Pharmacological Research|June 8, 2026
IUPHAR review. Gut Microbial Metabolites as Remote Regulators of Behavior and Neuropsychiatric DiseaseLiang Hao, Zi-Fei Li, Ya-Na Qu, et al.
Pharmacological Research|June 8, 2026
CLDN6 in Cancer: Biology, Clinical Significance, and Emerging Therapeutic StrategiesZhuo Yang, Mengxi Li, Jinyi Yang, et al.
Pageof 778